DOCSLIB.ORG

Public Opinion Toward the Expansion of Treatment Services in Virginia Amy Kyle Cook1* and Nicola Worcman2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Public Opinion Toward the Expansion of Treatment Services in Virginia Amy Kyle Cook1* and Nicola Worcman2 Cook and Worcman Health and Justice (2019) 7:13 Health and Justice https://doi.org/10.1186/s40352-019-0095-8 RESEARCH ARTICLE Open Access Confronting the opioid epidemic: public opinion toward the expansion of treatment services in Virginia Amy Kyle Cook1* and Nicola Worcman2 Abstract Background: Public opinion polls have consistently shown Americans prefer treatment over arrest policies for opioid users. As the opioid epidemic remains a major health problem in the United States, it is important to determine the type of treatment policies the public would support. Theoretically, government should take into consideration the opinion of its constituents when deciding how to act. As such, the 2018 Virginia Commonwealth Public Policy Poll determined levels of support for the expansion of community-based treatment in one’s community. Results: Overall, the results showed 80% of Virginians (n = 788) supported the expansion of community-based treatment centers in their neighborhood, 69% supported the use of housing in their community, while less than half supported the provision of clean needles to IV drug users so they do not use dirty needles that could spread infection. Multivariate analyses revealed education, sex, and political party affiliation are significant factors in predicting support for the expansion of services. Conclusions: Given the lack of progress made by the government in reducing the supply and demand of drugs over the course of the war on drugs, it is time to move away from punitive policies to responsible and pragmatic approaches that include the expansion of community-based treatment. Keywords: Opioids, Public opinion, Community-based treatment, Recovery housing, Needle exchange Background opioids at $78.5 billion annually, including increased costs Opioid use disorder remains a major health problem for health care, treatment, lost productivity, and criminal worldwide with 70% of the burden of disease attributable justice system involvement (Florence, Luo, Xu, & Zhou, to the use of opioids (United Nations Office on Drugs and 2016). Moreover, drug related deaths were attributed to a Crime [UNODC], 2017). The United States is responsible loss of .28 years in life expectancy (Dowell et al., 2017). for 25% of drug related deaths worldwide, mostly from the Globally it was estimated that 17 million years of life use of opioids (UNODC, 2017). In the United States in lost were attributable to drug use in 2015 alone 2017, there were over 72,000 fatal drug overdoses with over (UNODC, 2017). 47,000 the result of opioids (National Institute of Drug The impact of drug abuse has far-reaching conse- Abuse [NIDA], 2019). The effects of those numbers are quences in the lives of Americans. A recent public opin- profound considering more people die from the misuse of ion poll showed that 30% of respondents felt drug abuse opioids than do from car accidents or violence (UNODC, was a cause of trouble for their family (Gallup, 2018). 2017). Economists have estimated the United States’ When asked about the extent of the heroin problem in economic burden of both the dependence of and fatal their area, 47% of respondents reported heroin was a overdoses from heroin, prescription opioids, and synthetic very serious or somewhat serious problem with an add- itional 17% reporting it to be at crisis levels. Similar * Correspondence: [email protected] trends emerge with respect to prescription opioids. A 1L. Douglas Wilder School of Government and Public Affairs, Virginia number of public opinion polls show that addiction to Commonwealth University, 1001 W. Franklin Street, Richmond, VA 23284, USA prescription pain medication is a serious or major prob- Full list of author information is available at the end of the article lem nationally (CBS News Poll, 2018; Gallup, 2018; © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Cook and Worcman Health and Justice (2019) 7:13 Page 2 of 12 Kaiser Family Foundation, 2016; Marist Poll, 2017;AP- the coordination of any number of health and social ser- NORC Poll, 2018; Pew Research Center, 2017)with20to vices needed to meet client’s needs to encourage change of 54% of Americans knowing someone who has suffered behavior in the community (UNODC, 2014). Importantly, from opioid addiction (American Psychiatric Association, treatment services need to be available, accessible, 2017;CBSNewsPoll,2018; Marist Poll, 2017;Statand affordable and evidence-based to deliver quality care for all Harvard T.H. Chan, School of Public Health, 2016). More- people in need of support to help them reduce or stop the over, roughly 20 to 25% of Americans reported knowing use of alcohol and other drugs (UNODC, 2014). Given that someone who died from prescription opioid use (Kaiser drug use is also associated with increased healthcare prob- Family Foundation, 2017; Marist Poll, 2017;StatandHar- lems, particularly for people who inject drugs (PWID), vard T.H. Chan, School of Public Health, 2016). expanding prevention and treatment opportunities and Public opinion polls have also compared preferences for access is critical. treatment to criminal justice system responses. When Currently, the United States offers a broad range of faced with the choice to either increase access to treat- services based on evidence-based-programs designated for ment or impose stricter punishments and enforcement, people who use drugs; however, availability and access to Americans prefer policymakers increase access to treat- treatment for drug use remains a challenge. According to ment by 58% and 26%, respectfully (APA, 2017). Similarly, Substance Abuse and Mental Health Services Administra- the preference of treatment over arrest for prescription tion (2018), 20.7 million people in the United States were opioids and heroin use was found in other polls (Cook & estimated to need substance use treatment, yet only 2.5 Brownstein, 2017; Pew Research Center, 2014). Despite million received treatment. Some of the reasons for not the vast attention dedicated to the current opioid crisis, receiving treatment include not being ready to stop using, 43% of Americans believe the country is headed in the a lack of healthcare coverage, not being able to afford the wrong direction as opposed to only 20% who feel the cost of treatment, believing seeking treatment would have country is headed in the right direction in addressing the a negative impact on employment, stigma from others, opioid crisis; 37% were not sure (APA, 2017). Further- not knowing where to go for treatment, and not finding more, 37% of Americans feel the nation has lost ground in the type of treatment wanted (SAMSHA, 2018). Globally, making progress with the drug problem (Gallup, 2017). only one out of six people with drug use disorders has While the reasons are unknown as to why Americans access to treatment (UNODC, 2014, 2017). reported feeling the country is headed in the wrong dir- ection or that insufficient progress has been made in Recovery housing coping with the drug problem, it is important to con- Recovery housing or recovery residences are peer-run sider the observe public support for the expansion of sober living environments that support individuals in community-based treatment options. The following sec- their recovery from addiction or co-occurring mental tions discuss various programs through which communi- health and substance use disorders (National Association ties can utilize best practices to address the ever- Recovery Residences, 2012; Reif et al., 2014). Residents growing substance abuse crisis as a public health prob- living in recovery homes receive a variety of services lem. These include community-based treatment, recov- such as case management, therapeutic recreational activ- ery housing, and needle-exchange programs. ities, and peer support in order to improve functioning with the ultimate goal of integration back into the com- Community-based treatment munity (Reif et al., 2014). Safe and stable living environ- Community-based treatment refers to comprehensive out- ments are important to the recovery process especially patient health care and psychiatric services offered in the for individuals with substance use disorders who need community (United Nations Office on Drugs and Crime more structured care, typically after release from an [UNODC], 2014). Based on a bio-psycho-social approach, inpatient facility (Reif et al., 2014). Often times those community-based treatments are designed to help people released from jail or prison are also in need of safe and with substance use problems develop the skills to manage stable living environments to continue recovery efforts. their addiction in the community using a continuum of Blue and Rosenberg (2017) describe recovery housing as care model that reduces the need for residential and custo- an essential component to the recovery process and dial services where possible (UNODC, 2014). According to without it, they contend recovery from addiction is UNODC (2014), community-based treatments are the most unlikely, particularly given the challenges associated with cost-effective method addressing drug use and dependence low recovery capital. Low recovery capital
Load more

Recommended publications
  • The Effects of Recreational Marijuana Legislation on the Opioid Epidemic in Washington State" (2018)
    Claremont Colleges Scholarship @ Claremont CMC Senior Theses CMC Student Scholarship 2018 The ffecE ts of Recreational Marijuana Legislation on the Opioid Epidemic in Washington State Steven Dickerson Claremont McKenna College Recommended Citation Dickerson, Steven, "The Effects of Recreational Marijuana Legislation on the Opioid Epidemic in Washington State" (2018). CMC Senior Theses. 1757. http://scholarship.claremont.edu/cmc_theses/1757 This Open Access Senior Thesis is brought to you by Scholarship@Claremont. It has been accepted for inclusion in this collection by an authorized administrator. For more information, please contact [email protected]. Claremont McKenna College ​ ​ ​ ​ The Effects of Recreational Marijuana Legislation on the Opioid Epidemic ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ in Washington State ​ ​ ​ ​ Submitted to ​ ​ Professor David Bjerk ​ ​ ​ ​ By: Steven Reid Dickerson Jr. ​ ​ ​ ​ ​ ​ ​ ​ for Senior Thesis ​ ​ Fall 2017 ​ ​ December 4th ​ ​ Table of Contents ​ ​ ​ ​ Abstract 2 Acknowledgments 3 Introduction 4 Literature Summary 7 ​ ​ A History of the Opioid Epidemic 7 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ The History of Marijuana Legislation in the United States 10 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ The Effect of Marijuana Laws on Opioid Usage 12 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Data 13 Opioid Overdose Crude Death Rate 14 ​ ​ ​ ​ ​ ​ ​ ​ Self-Reported Drug Usage 15 ​ ​ ​ ​ Treatment Admissions 15 ​ ​ Empirical Strategy 16 ​ ​ Analysis 19 Opioid Overdose Crude Death Rates 19 ​ ​ ​ ​ ​ ​ ​ ​ Self-Reported Opioid Usage 24 ​ ​ ​ ​
    [Show full text]
  • Medications to Treat Opioid Use Disorder Research Report
    Research Report Revised Junio 2018 Medications to Treat Opioid Use Disorder Research Report Table of Contents Medications to Treat Opioid Use Disorder Research Report Overview How do medications to treat opioid use disorder work? How effective are medications to treat opioid use disorder? What are misconceptions about maintenance treatment? What is the treatment need versus the diversion risk for opioid use disorder treatment? What is the impact of medication for opioid use disorder treatment on HIV/HCV outcomes? How is opioid use disorder treated in the criminal justice system? Is medication to treat opioid use disorder available in the military? What treatment is available for pregnant mothers and their babies? How much does opioid treatment cost? Is naloxone accessible? References Page 1 Medications to Treat Opioid Use Disorder Research Report Discusses effective medications used to treat opioid use disorders: methadone, buprenorphine, and naltrexone. Overview An estimated 1.4 million people in the United States had a substance use disorder related to prescription opioids in 2019.1 However, only a fraction of people with prescription opioid use disorders receive tailored treatment (22 percent in 2019).1 Overdose deaths involving prescription opioids more than quadrupled from 1999 through 2016 followed by significant declines reported in both 2018 and 2019.2,3 Besides overdose, consequences of the opioid crisis include a rising incidence of infants born dependent on opioids because their mothers used these substances during pregnancy4,5 and increased spread of infectious diseases, including HIV and hepatitis C (HCV), as was seen in 2015 in southern Indiana.6 Effective prevention and treatment strategies exist for opioid misuse and use disorder but are highly underutilized across the United States.
    [Show full text]
  • The Opioid Epidemic: What Labs Have to Do with It?
    The Opioid Epidemic: What labs have to do with it? Ewa King, Ph.D. Associate Director of Health RIDOH State Health Laboratories Analysis. Answers. Action. www.aphl.org Overview • Overdose trends • Opioids and their effects • Analytical testing approaches • Toxicology laboratories Analysis. Answers. Action. www.aphl.org Opioid overdose crisis 1 Analysis. Answers. Action. www.aphl.org Opioid overdose crisis 2 Analysis. Answers. Action. www.aphl.org Opiates and Opioids • Opiates vs. Opioids • Opiates: Naturally occurring, derived from the poppy plant • Opioids: “Opiate-like” drugs in effects, not chemical structure Includes opiates • Narcotic analgesics • CNS depressants • DEA Schedule I or II controlled substances • Additive effect with other CNS depressant drugs Analysis. Answers. Action. www.aphl.org Efficacy of Opioids • How do opioids work? • Bind with opioid receptors • Brain, spinal cord, GI tract, and throughout the body • Pain, emotion, breathing, movement, and digestion Opioid Receptor Analysis. Answers. Action. www.aphl.org Effects of Opioids Physiological Psychological • Pain relief • Drowsiness/ sedation • Cough suppression • Mental confusion • GI motility • Loss of memory • Respiratory depression • Lethargy/ apathy • Pupillary constriction • Euphoria/ tranquility • Itching • Mood swings • Constipation • Depression • Dependence • Withdrawal • Dependence Analysis. Answers. Action. www.aphl.org Opiates 1 Opiates • Naturally occurring alkaloids Opium • Latex from the opium poppy plant Codeine: • Mild to moderate pain • Antitussive Morphine: • Severe pain • Metabolite of codeine and heroin Analysis. Answers. Action. www.aphl.org Opiates 2 Semi-synthetic Opiates: • Synthesized from a natural opiate Heroin: • Schedule I narcotic Hydrocodone (Vicodin): • Mild to moderate pain • Metabolizes to hydromorphone (Dilaudid) Oxycodone (Oxycontin/Percocet): • Moderate to severe pain • Metabolizes to oxymorphone (Opana) Analysis. Answers. Action.
    [Show full text]
  • Washington DC's Opioid Strategic Plan
    Updated as of March 2019 Letter from Mayor Muriel Bowser Too many of our neighbors in Washington, DC lose their lives or family members and friends to a substance use disorder. Many of these cases involve opioid overdoses. The District’s multi-stakeholder, public health approach has yielded progress in saving lives and reducing fatal overdoses, but there is still work to be done to reduce the impact of the epidemic on our city. “LIVE.LONG.DC,” Washington, DC’s Strategic Plan to Reduce Opioid Use, Misuse and Related Deaths is our blueprint for how best to continue moving forward with urgency and thoughtfulness as we work towards reversing fatal opioid overdoses. The Plan reflects the input of a cross-section of public and private partners, including DC government agencies, hospital leaders, physicians, substance use disorder treatment providers, community-based service providers, federal partners, and individuals in recovery. The updated Plan offers a comprehensive look at prevention, treatment, and recovery, detailing our goals and accompanying strategies to end Washington, DC’s opioid epidemic. Our Plan offers additional details on how these goals and strategies will be accomplished in order to ensure District residents can thrive and move forward with the support they need. Working together, the implementation of LIVE.LONG.DC has resulted in some early successes, which include: Reversing more than 1,000 overdoses through naloxone kits and training residents in naloxone use; Increasing the capacity of practitioners to provide Buprenorphine-based medication-assisted treatment (MAT); Monitoring trends in opioid use and tailoring responses and interventions based on real-time data; Increasing testing capacity via surveillance of synthetic opioids in the District, both to discover new synthetic opioids as well as characterize those currently present; and Revising innovative public education campaigns targeting those who are most likely to overdose on heroin and to educate young people on the dangers of misusing prescription opioids.
    [Show full text]
  • The Biden-Harris Administration's Statement of Drug Policy Priorities
    EXECUTIVE OFFICE OF THE PRESIDENT OFFICE OF NATIONAL DRUG CONTROL POLICY Washington, DC 20503 The Biden-Harris Administration’s Statement of Drug Policy Priorities for Year One The overdose and addiction crisis has taken a heartbreaking toll on far too many Americans and their families. Since 2015, overdose death numbers have risen 35 percent, reaching a historic high of 70,630 deaths in 2019.1 This is a greater rate of increase than for any other type of injury death in the United States.2 Though illicitly manufactured fentanyl and synthetic opioids other than methadone (SOOTM) have been the primary driver behind the increase, overdose deaths involving cocaine and other psychostimulants, like methamphetamine,3 have also risen in recent years, particularly in combination with SOOTM. New data suggest that COVID-19 has exacerbated the epidemic,4, 5 and increases in overdose mortality6 have underscored systemic inequities in our nation’s approach to criminal justice and prevention, treatment, and recovery. President Biden has made clear that addressing the overdose and addiction epidemic is an urgent priority for his administration. In March, the President signed into law the American Rescue Plan, which appropriated nearly $4 billion to enable the Substance Abuse and Mental Health Services Administration and the Health Resources and Services Administration to expand access to vital behavioral health services. President Biden has also said that people should not be incarcerated for drug use but should be offered treatment instead. The President has also emphasized the need to eradicate racial, gender, and economic inequities that currently exist in the criminal justice system.
    [Show full text]
  • The Opioid Epidemic: a Geography in Two Phases David A
    A report summary from the Economic Research Service April 2021 The Opioid Epidemic: A Geography in Two Phases David A. McGranahan and Timothy S. Parker What Is the Issue? Since the late 1990s, an opioid epidemic has afflicted the U.S. population, particularly people in prime working ages of 25-54. Driven by the opioid epidemic, the age-adjusted overall mortality rate from drug overdoses rose from 6.1 per 100,000 people in 1999 to 21.7 per 100,000 in 2017, before dropping to 20.7 per 100,000 in 2018. The drug overdose mortality rate among the prime working age population was 36.5 deaths per 100,000 people in 2018. Among major causes of death in this population, this rate was exceeded only by cancer (40.5 deaths per 100,000) in 2018. What caused this epidemic, and who has been most affected? One view is that economic misfor- tune has driven many working-age people to self-destructive behavior—marked by increasing drug and alcohol abuse and suicide. However, another line of research shows that local economic downturns have been a small factor in the geography of the drug overdose epidemic. A second view faults the widespread introduction of new opioid prescription painkillers, succeeded in recent years by the spread of heroin and powerful synthetics such as fentanyl. This view, which has received less research attention, is the focus of this study. What Did the Study Find? The study found evidence that the introduction and supply of new opioid drugs, whether through prescription painkillers in the 2000s or illicit opioids such as fentanyl in the 2010s, were major drivers of the opioid epidemic.
    [Show full text]
  • The Opioid Crisis and the Black/African American Population: an Urgent Issue
    THE OPIOID CRISIS AND THE BLACK/AFRICAN AMERICAN POPULATION: AN URGENT ISSUE THE OPIOID CRISIS AND THE BLACK/AFRICAN AMERICAN POPULATION: AN URGENT ISSUE U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Behavioral Health Equity Table of Contents Introduction ...................................................................................................................................................... 3 i. Purpose of the Issue Brief ........................................................................................................................ 3 ii. Sources of Information ............................................................................................................................ 4 Opioids in Black/African American Communities: Context .................................................................. 4 i. What Do the National Data Show? ........................................................................................................ 4 ii. Routes to Opioid Misuse and Overdose Deaths: Pain Management, Illicit Drug Use, and Opioid Comorbidities in Black/African American Communities .................................................... 6 iii. Challenges to Prevention, Treatment, and Recovery .......................................................................... 7 Strategies to Address Opioid Misuse and OUD in Black/African American Communities ............ 9 i. Standard Treatment ................................................................................................................................
    [Show full text]
  • The Effect of Medical Cannabis Legalization on the Medicaid
    The Effect of Medical Cannabis Legalization on the Medicaid Opioid Prescription Rate Nathaniel Downes MMSS Senior Thesis Advisor: Diane Whitmore Schanzenbach ;1 Acknowledgements I would like to thank the MMSS program at Northwestern University for providing me with the opportunity to do this research project, and Professor Joseph Ferrie and Nicole Schneider for all their help through this process. I would also like to thank Professor Diane Schanzenbach for her invaluable advice and support as an advisor; without her expertise I would never have been able to finish this thesis. I also want to thank my family, who have provided me the opportunity to aend Northwestern and have supported me throughout my time here. Lastly, I want to thank my dad, Tom Downes; you have been more helpful than I ever could have hoped a person could be through every step of producing this thesis. You were always there to answer my questions and give me guidance as to how to tackle problems, and I can’t thank you enough for everything you’ve done to help bring this thesis into being. Abstract The opioid epidemic has become one of the most pressing public health issues over the past two decades as both prescription and overdose rates have risen. One proposal to curb the prescription rate of opioids is the use of medical cannabis as a substitute painkiller. This paper examines the effect of medical cannabis on the prescription rate of opioids among Medicaid participants. Using three variations on a difference-in-differences approach, I find that medical cannabis implementation produces a reduction in the Medicaid opioid prescription rate of around 10%, which first appears about a year post-implementation and remains steady in subsequent years.
    [Show full text]
  • Why Marijuana Will Not Fix the Opioid Epidemic Page 8
    AUGUST | SEPTEMBER 2018 UTAHStill the Greatest Profession.PHYSICIAN WHY MARIJUANA WILL NOT FIX THE OPIOID EPIDEMIC PAGE 8 EXPANDING THE THE IMPACT OF INFLATION CANDIDATES FOR UMA OFFICE POSSIBILITIES OF PAGE 20 FOR 2018-2019 HEALTH PAGE 23 www.utahmed.org PAGE 10 Why Marijuana Will Not Fix the Opioid Epidemic BY KENNETH FINN, MD, ORIGINALLY PUBLISHED IN MISSOURI MEDICINE, OFFICIAL PUBLICATION OF THE MISSOURI MEDICAL ASSOCIATION ARIJUANA HAS BEEN USED for reported medical purposes M for thousands of years when the plant at that time had THC content of 0.5-3%. Currently, the most common reported medical use is for pain. As of this writing there are 30 states and the District of Columbia have some form of legal- ized marijuana, with eight states having legalized for recreational use. The United States is currently in the grips of an opioid epidemic which has been growing over the last 20 years and began with “pain” being termed the “5th vital sign.” At the time, it was reported that people in pain did not become addicted to opioids, and the number of opioid prescriptions started to increase of people who may be using opioids and/ which effects neurotransmission. Receptor over time, followed by an increase in opioid or medical marijuana. In 2017 Colorado activation of both also modifies the perme- overdose deaths.1 had a record number of opioid overdose ability of sodium, potassium, and calcium deaths from any opioid, including heroin channels and receptors of both systems co- There has been a lot of discussion about and Colorado has had
    [Show full text]
  • THE OPIOID EPIDEMIC from Evidence to Impact the OPIOID EPIDEMIC from Evidence to Impact
    THE OPIOID EPIDEMIC From Evidence to Impact THE OPIOID EPIDEMIC From Evidence to Impact October 2017 Prepared by Johns Hopkins Bloomberg School of Public Health, and the Clinton Foundation, Clinton Health Matters Initiative Cite as: Alexander GC, Frattaroli S, Gielen AC, eds. The Opioid Epidemic: From Evidence to Impact. Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland: 2017. The growing crisis of the U.S. opioid epidemic affects all of us, not just those caught in its grip. It is destroying lives, ripping families apart, weakening our communities, and preventing our country from taking full advantage of our greatest resource – our people. We ignore the problem at our peril. We can’t afford to lose a single person. There is no single solution to this grave public health threat, but we know where to start. First we must acknowledge that opioid addiction is a disease that requires comprehensive treatment. Closing the path to addiction means addressing the overprescription of legal opioids and the proliferation of illegal opioids such as heroin and drugs laced with fentanyl. We also have to build the public health response so that families, first responders, and community groups have the support necessary to turn the tide on the epidemic, and in the meantime don’t have to bear an impossible economic and emotional burden. This report contains specific, proven recommendations for how to most effectively combat the epidemic – from allowing physicians to more effectively treat those suffering from addiction; to expanding coverage and accessibility of opioid overdose reversal drugs like naloxone; to changing the way that health care professionals, employers, and advocates talk about addiction to reduce stigma.
    [Show full text]
  • The Ripple Effect National and State Estimates
    National and State Estimates of the U.S. Opioid Epidemic’s The Ripple Effect Impact on Children Acknowledgments This chartbook was authored by Suzanne C. Brundage, colleagues Carol Levine, senior fellow; Chad Shearer, director of United Hospital Fund’s Children’s Health senior vice president for policy and program; and Anthony Initiative; Adam Fifield, UHF’s director of communications; Shih, MD, president. We are especially grateful to Carol and Lee Partridge, UHF senior fellow. The analysis was Levine for inspiring this work with her 1992 Journal of the produced as a collaboration between UHF and Boston American Medical Association article, “Estimates of the Consulting Group through a pro-bono engagement. Special Number of Motherless Youth Orphaned by AIDS in the thanks to Boston Consulting Group’s Edoardo Cavallazzi, United States” (coauthored with David Michaels), and for Leonardo Fascione, and Jacob Luce, working under the her ongoing collaboration. Laurie Douglas designed the direction of Christophe Durand and Bob Lavoie, for chartbook. UHF’s Children’s Health Initiative is supported creating the analytic model and providing their expertise. in part by the Ira W. DeCamp Foundation and the William This chartbook also benefited from the insights of UHF J. and Dorothy K. O’Neill Family Foundation. November 2019 UHF works to build a more effective health care system for every New Yorker. An independent, nonprofit organization, we analyze public policy to inform decision-makers, find common ground among diverse stakeholders, and develop and support innovative programs that improve the quality, accessibility, affordability, and experience of patient care. To learn more, visit www.uhfnyc.org or follow us on Twitter at @UnitedHospFund.
    [Show full text]
  • Medical Marijuana Laws and Opioid Overdose Deaths in the United States
    University of Pennsylvania Carey Law School Penn Law: Legal Scholarship Repository Prize Winning Papers Student Papers 2019 Medical Marijuana Laws and Opioid Overdose Deaths in the United States Gregory Schuster University of Pennsylvania Follow this and additional works at: https://scholarship.law.upenn.edu/prize_papers Part of the Law Commons Repository Citation Schuster, Gregory, "Medical Marijuana Laws and Opioid Overdose Deaths in the United States" (2019). Prize Winning Papers. 12. https://scholarship.law.upenn.edu/prize_papers/12 This Prize Paper is brought to you for free and open access by the Student Papers at Penn Law: Legal Scholarship Repository. It has been accepted for inclusion in Prize Winning Papers by an authorized administrator of Penn Law: Legal Scholarship Repository. For more information, please contact [email protected]. Medical Marijuana Laws and Opioid Overdose Deaths in the United States Gregory Schuster I. Abstract Several studies have found that medical marijuana laws reduce opioid overdose death rates. I attempted to confirm these findings using the most recent data available. I used state- level death certificate data from 1999 to 2017 to compare changes in opioid overdose death rates following the implementation of medical marijuana laws in states that implemented such laws and states that did not. I found no significant difference in opioid overdose death rate changes following the implementation of medical marijuana laws. These findings do not undermine the primary justifications for legalizing medical marijuana, but they do suggest that legalizing medical marijuana will not solve the ongoing opioid epidemic. II. Introduction A. Background The U.S. has been ravaged by an opioid epidemic that has occurred in three waves.
    [Show full text]